Get ready to discover the eagerly anticipated third quarter financial results of Vir Biotechnology (NASDAQ: VIR) on Thursday 31st October 2024. This significant announcement is scheduled to take place after market close, giving investors and analysts a chance to gain valuable insights into the company's financial performance.
the company is poised to announce an estimated $1.05 loss per share for the quarter, as predicted by financial experts on Wall Street. Additionally, the firm is expected to reveal a total revenue of $5.51 million for this period.
The experts on Wall Street have shared their predictions for how well the company will do this year. They think the total revenue will be around $70.92 million. They also believe the company will reach about loss of $3.39 per share for the fiscal year.
During the same quarter of the previous year, the company's earnings report indicated a per-share loss of $1.22. This noteworthy figure was a direct outcome of the company's total revenue, which reached an impressive $2.64 million during that specific period.
Additionally, The company will host a conference call with investors and analysts on 31st October 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
The previous trading day saw Vir Biotechnology (VIR) shares trading between $7.56 and $7.78, besides a volume of 782.10 thousand shares. The stock closed Tuesday's regular trading session at $7.61, reflecting 1.81 percent downfall.